AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 286: G412-G419, 2004. First published October 30, 2003; doi:10.1152/ajpgi.00403.2003
0193-1857/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
286/3/G412    most recent
00403.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (15)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuemmerle, J. F.
Right arrow Articles by Bowers, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuemmerle, J. F.
Right arrow Articles by Bowers, J. G.

HORMONES AND SIGNALING

IGF-I stimulates human intestinal smooth muscle cell growth by regulation of G1 phase cell cycle proteins

John F. Kuemmerle, Huiping Zhou, and Jennifer G. Bowers

Departments of Medicine and Physiology, Medical College of Virginia Campus, Virginia Commonwealth University

Submitted 16 September 2003 ; accepted in final form 27 September 2003

Autocrine production of insulinlike growth factor-I (IGF-I) regulates growth of human intestinal muscle cells by activation of distinct phosphatidylinositol 3-kinase (PI3-kinase)-dependent and ERK1/2-dependent pathways. The aim of the present study was to determine the mechanisms by which IGF-I regulates the G1 phase of the cell cycle and muscle cell proliferation. Incubation of quiescent cells with IGF-I stimulated time-dependent cell cycle progression measured by using fluorescence-activated cell sorting analysis and by incorporation of [3H]thymidine. Studies using a microarray-based approach were used initially to identify genes expressed in human intestinal muscle encoding proteins known to participate in the G1 phase of the cell cycle that were regulated by IGF-I. Incubation of muscle cells for 24 h with IGF-I elicited greater than fivefold increase in the expression of cyclin D1 and greater than twofold increase in retinoblastoma protein (Rb1). IGF-I elicited a time-dependent increase in cyclin D1 protein levels mediated jointly by ERK1/2-dependent and PI3-kinase-dependent mechanisms. Increase in cyclin D1 levels was accompanied by a time-dependent increase in cyclin D1-dependent cyclin-dependent kinase-4 (CDK4) activity. IGF-I also elicited a rapid time-dependent increase in Rb-(Ser807/811) phosphorylation, the specific target of the cyclin D1-dependent CDK4 kinase, and a slower increase in total Rb protein levels. We conclude that IGF-I stimulates G1 phase progression, DNA synthesis, and cell proliferation of human intestinal smooth muscle cells. Effects of IGF-I on proliferation are mediated jointly by ERK1/2-dependent and PI3-kinase-dependent pathways that regulate cyclin D1 levels, CDK4 activity, and Rb activity.

retinoblastoma; cyclin D; cyclin-dependent kinase; extracellular signal-regulated kinase 1/2; phosphatidylinositol 3-kinase



Address for reprint requests and other correspondence: J. F. Kuemmerle, Div. of Gastroenterology, Medical College of Virginia Campus, Virginia Commonwealth Univ., PO Box 980711, Richmond, VA 23298-0711 (E-mail: jkuemmerle{at}hsc.vcu.edu).




This article has been cited by other articles:


Home page
CarcinogenesisHome page
M. Pacher, M. J. Seewald, M. Mikula, S. Oehler, M. Mogg, U. Vinatzer, A. Eger, N. Schweifer, R. Varecka, W. Sommergruber, et al.
Impact of constitutive IGF1/IGF2 stimulation on the transcriptional program of human breast cancer cells
Carcinogenesis, January 1, 2007; 28(1): 49 - 59.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. F. Kuemmerle
Endogenous IGF-I protects human intestinal smooth muscle cells from apoptosis by regulation of GSK-3{beta} activity
Am J Physiol Gastrointest Liver Physiol, January 1, 2005; 288(1): G101 - G110.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. F. Kuemmerle, K. S. Murthy, and J. G. Bowers
IGFBP-3 activates TGF-{beta} receptors and directly inhibits growth in human intestinal smooth muscle cells
Am J Physiol Gastrointest Liver Physiol, October 1, 2004; 287(4): G795 - G802.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.